Shree Ganesh Bio-Tech
0.59
-0.02(-3.28%)
Market Cap₹23.50 Cr
PE Ratio61.00
IndustryHealthcare
Company Performance:
1D-3.28%
1M-14.49%
6M-14.49%
1Y-35.16%
5Y-90.17%
View Company Insightsright
More news about Shree Ganesh Bio-Tech
25Jul 25
Shree Ganesh Biotech Reports 37.5% Jump in Net Profit for Quarter Ended June
Shree Ganesh Bio-Tech (India) Limited reported a net profit of Rs. 32.70 lacs for Q1, up 37.5% year-over-year, despite a 61.1% decline in revenue to Rs. 138.36 lacs. Total income fell 54.2% to Rs. 179.89 lacs, while expenses were reduced by 60.1% to Rs. 147.19 lacs. The company maintained its EPS at Rs. 0.01. The Board of Directors approved these unaudited financial results on July 25.
 no imag found
Shree Ganesh Bio-Tech
0.59
-0.02
(-3.28%)
1 Year Returns:-35.16%
Industry Peers
Anthem Biosciences
787.35
(-0.19%)
Advanced Enzyme Tech
386.30
(+6.20%)
CCME Global
116.90
(0.0%)
Vivo Bio Tech
26.98
(-0.26%)